Total sales growth (fiscal Q4, period ended Jan. 31, 2026) -- 11%, on top of 10% growth in the prior year, demonstrating consecutive double-digit quarterly increases. Adjusted EPS (fiscal Q4) -- $4.99 ...

Good morning, and welcome to the ImmuCell Corporation Conference Call to discuss Unaudited Fourth Quarter and Full Year 2025 Financial Results. Please note, this event is being recorded. I would now ...

Wall Street is in a downward pattern after days of volatility. Markets have been buffeted by developments in the conflict in Iran, now entering it's sixth day.